Mar 28, 2020

Henry Schein Q1 2020 Earnings Report

Henry Schein's Q1 2020 financial results were reported, showing an increase in net sales and EPS compared to the previous year, but were significantly impacted by the COVID-19 pandemic in March.

Key Takeaways

Henry Schein reported a 2.9% increase in net sales to $2.4 billion for Q1 2020. GAAP diluted EPS from continuing operations was $0.91, and non-GAAP diluted EPS was $0.94. The company's results were significantly impacted by the COVID-19 pandemic, particularly in the Dental business.

Q1 GAAP diluted EPS from continuing operations was $0.91, up from $0.78 in the prior year.

Q1 non-GAAP diluted EPS from continuing operations was $0.94, compared to $0.80 in the prior year.

Net sales increased by 2.9% to $2.4 billion, driven by 4.0% growth in local currencies.

The COVID-19 pandemic significantly impacted the Dental business, while Medical and Technology and Value-Added Services businesses were more resilient.

Total Revenue
$2.43B
Previous year: $2.36B
+2.9%
EPS
$0.94
Previous year: $0.8
+17.5%
Gross Profit
$746M
Previous year: $752M
-0.8%
Cash and Equivalents
$617M
Previous year: $88.1M
+600.6%
Total Assets
$7.52B
Previous year: $7.14B
+5.2%

Henry Schein

Henry Schein

Henry Schein Revenue by Segment

Henry Schein Revenue by Geographic Location

Forward Guidance

Henry Schein withdrew its previously announced financial guidance for 2020 due to the continued uncertainty surrounding COVID-19 and its impact on business operations.

Revenue & Expenses

Visualization of income flow from segment revenue to net income